Search

The current research provides a newly developed method to quantify methanol-soluble organic carbon (MeS_OC) in aerosol samples. This analytical procedure allows an accurate separation of MeS-OC component, which is critical for the calculation of mass absorption efficiency (MAE) of ambient Brown Carbon (BrC) and consequently its climate relevant potential. The method includes extraction, filtering and condensation stages, leading to the preparation of a highly concentrated product in which MeS-OC can be precisely quantified by a Sunset Carbon Analyzer in a single analysis step. This method can be applied on aerosol collected using either high or low volume samplers, since a relatively small filter area is required for the determination. Furthermore, it eliminates any misestimation of the MeS-OC mass that may appear in other reported techniques that don't seem to include the precise separation of methanol-soluble fraction in their quantification process.•The mass quantification of methanol-soluble organic carbon is essential, contributing up to 50% to the absorptivity of organic aerosol (BrC) at shorter wavelengths.•The method provides a direct measurement of methanol-soluble aerosol components, resolving any potential uncertainties of previously applied methods.•The adoption of this direct quantification approach leads to a rationalization of past MAE estimates for BrC with implications for radiative transfer models., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Author(s).)

His bundle pacing (HBP) is proven to be a safe and effective alternative pacing modality that, in addition, avoids pacemaker-induced cardiomyopathy (PICM) by achieving a "physiological" ventricular stimulation, via the native conduction system. Indications include various causes of bradycardia requiring anti-bradycardic pacing, inadequately controlled atrial fibrillation requiring AV node ablation and established PICM. In addition, HBP may also be used as an alternative therapy for patients with heart failure (HF) and an indication for cardiac resynchronization therapy (CRT). Available data show several advantages of HBP with regard to preservation or restoration of intra- and inter-ventricular synchronization; improvement in left ventricular ejection fraction, functional status and quality of life; decrease in atrial fibrillation incidence and improvement in HF hospitalization rates, compared with conventional pacing. Nevertheless, superiority in terms of mortality rates has not been consistently demonstrated, and the long-term efficacy and safety of HBP remain to be proven. In the present manuscript, we review the status of HBP and present our current experience with this novel pacing modality., (Copyright © 2021 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.)